NASDAQ:HZNP
Delisted
Horizon Therapeutics Public Ltd Co Stock News
$116.30
+0 (+0%)
At Close: Jan 04, 2024
Amgen quarterly profit rises 15% as Horizon deal boosts results
04:05pm, Tuesday, 06'th Feb 2024
Amgen on Tuesday said its adjusted fourth-quarter profit rose 15%, driven by a 20% increase in revenue following the biotechnology company's October acquisition of rare disease drugmaker Horizon Thera
5 Biotech Acquisition Targets To Accumulate In 2024
01:05pm, Thursday, 21'st Dec 2023
Valuations in the biotech market have fallen, making it a good time for acquisitions in the industry. Investors should focus on commercial-stage biotech companies that generate revenue, as they provid
Amgen: Horizon's Pipeline May Be Too Expensive
02:00pm, Friday, 13'th Oct 2023
We believe that AMGN has overpaid for HZNP's pipeline, since most of its upside potential is attributed to price increases instead of the expanding TAM. The growing debt may also pose headwinds to its
Amgen completes $27.8 bln Horizon deal
09:18am, Friday, 06'th Oct 2023
Amgen said on Friday it had completed the $27.8 billion acquisition of Horizon Therapeutics after it received the go-ahead from the U.S. Federal Trade Commission (FTC) last month on certain conditions
3 Growth Stocks to Buy in September
10:56am, Wednesday, 06'th Sep 2023
We're now into September, and that means many investors wonder if the September effect will be in place. This speaks to the historical trend of stocks underperforming in September compared to other mo
The FTC cleared Amgen's $27.8 billion Horizon buyout — here's what it means for other massive pharma deals
12:56pm, Tuesday, 05'th Sep 2023
Some analysts and M&A experts say the settlement agreement doesn't mean that the FTC will stop baring its teeth at other large buyouts in the industry.
Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement
09:05am, Tuesday, 05'th Sep 2023
DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics Announces Date of Irish Court Hearing to Sanction Scheme of Arrangement.
Amgen gets green light from FTC for $27.8B Horizon Therapeutics deal
02:11pm, Friday, 01'st Sep 2023
The Federal Trade Commission will allow Amgen to continue a $27.8 billion purchase of Horizon Therapeutics. The companies anticipate closing the deal in the fourth quarter.
FTC clears Amgen's $28 billion acquisition of Horizon Therapeutics
11:59am, Friday, 01'st Sep 2023
Shares of Horizon Therapeutics PLC (NASDAQ: HZNP) are trading materially up today after the FTC allowed Amgen Inc (NASDAQ: AMGN) to move forward with its $27.8 billion acquisition of the biopharmaceut
Amgen's $27.8 Billion Purchase Of Horizon Therapeutics On After FTC Settlement
10:53am, Friday, 01'st Sep 2023
The agency previously argued the merger could harm patients who are prescribed Horizon's two fastest-growing drugs.
Amgen, Horizon Therapeutics Stocks Rise After FTC Settlement Over $27.8 Billion Merger
10:11am, Friday, 01'st Sep 2023
The Federal Trade Commission makes provision that prohibits “bundling” discounts for some medications.
FTC allows Amgen to move forward with $27.8 billion Horizon Therapeutics deal
09:33am, Friday, 01'st Sep 2023
CNBC's Emily Wilkins joins 'Squawk Box' with the latest news.
FTC settles with Amgen over $27.8 billion takeover of Horizon Therapeutics
09:20am, Friday, 01'st Sep 2023
The Federal Trade Commission reached a deal with Amgen Inc. AMGN, -0.60% to approve its $27.8 billion acquisition of Horizon Therapeutics plc, HZNP, -0.07% the agency announced Friday.
U.S. FTC allows Amgen to move forward with $27.8 bln Horizon deal - CNBC
09:04am, Friday, 01'st Sep 2023
The U.S. Federal Trade Commission has allowed drugmaker Amgen Inc to move ahead with its $27.8 billion deal to buy Horizon Therapeutics , CNBC reported on Friday.
FTC, Amgen strike deal to allow $27.8 billion Horizon Therapeutics acquisition to move forward
08:49am, Friday, 01'st Sep 2023
The FTC had filed a lawsuit in May seeking to block the acquisition, arguing that the deal would "stifle competition" in the pharmaceutical industry.